KOR

e-Article

Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
Document Type
Artikel
Source
Journal of the American Academy of Dermatology. 89(3):486-495
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1097-6787